Review
. 2006 Jan;85(1):44-5; discussion 48-50.
doi: 10.1016/j.fertnstert.2005.09.014.
New uterine-preserving therapies raise questions about interdisciplinary management and the role of surgery for symptomatic fibroids
Affiliations
- PMID: 16412725
- DOI: 10.1016/j.fertnstert.2005.09.014
Item in Clipboard
Review
New uterine-preserving therapies raise questions about interdisciplinary management and the role of surgery for symptomatic fibroids
Fertil Steril.
2006 Jan.
Free article
Abstract
Mounting evidence to support the safety and effectiveness of new uterine-preserving fibroid therapies is raising questions not only about changing indications for surgery but also about gynecologists' role in therapies offered by other specialists. New collaborative relationships are needed to provide the best possible treatment; without them, those lag times of 10-15 years often cited as the time it takes for advances in clinical research to diffuse into clinical practice will be even longer for women with symptomatic fibroids.
Comment on
-
Uterine artery embolization versus myomectomy: a multicenter comparative study.Fertil Steril. 2006 Jan;85(1):14-21. doi: 10.1016/j.fertnstert.2005.05.074. Fertil Steril. 2006. PMID: 16412720 Clinical Trial.
-
Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids.Fertil Steril. 2006 Jan;85(1):22-9. doi: 10.1016/j.fertnstert.2005.04.072. Fertil Steril. 2006. PMID: 16412721 Clinical Trial.
-
Failure of uterine fibroid embolization.Fertil Steril. 2006 Jan;85(1):30-5. doi: 10.1016/j.fertnstert.2005.03.091. Fertil Steril. 2006. PMID: 16412722
-
Abdominal myomectomy in women with very large uterine size.Fertil Steril. 2006 Jan;85(1):36-9. doi: 10.1016/j.fertnstert.2005.05.073. Fertil Steril. 2006. PMID: 16412723
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
